Equity
€44,707 ▲ 11.5%
Vitapharma.be has made a profit without a break since 2010.
Vitapharma.be
Lifetime
18 annual accounts with figures on one time axispeak €51,143 (2025)
€51,143▲ 21.7%
lowest -€29,402 (2008)
€4,598▲ 30.0%
peak €44,707 (2025)
€44,707▲ 11.5%
€334,580▼ 2.3%
peak 0 FTE (2024)
-not published
Board2 names since 2019
-
Documentsfilings and deeds
15-12-2025136 days before the deadline
2025micro format
Gross margin from €42,023 to €51,143Result from €3,537 to €4,598
Key points
from the 2025 annual accountsChecked score
86
Excellent
Financially stronger than 47% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,275 companies (NACE 47, micro).
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.4%highest value
01-2025: 0.2%▼ -0.2 percentage points vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: 0.2%● unchanged vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025lowest value
01-2026: 0.3%▲ +0.1 percentage points vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.3%● unchanged vs 07-2026
09-2026: 0.3%● unchanged vs 08-2026
10-2026: 0.3%● unchanged vs 09-2026
11-2026: 0.3%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Equity €44,707 (11.8% of total assets)
Sector: Retail trade (NACE 47)
lowers risk
Size: total assets €379,287
Founded in 2006
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 28% of them on solvency, 55% on liquidity, 41% on profitability and 63% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-09-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 3,984 companies had the same profile as Vitapharma.be has now. Each dot stands for 10 companies, two years later.
96.5%
were still trading
2.3%
stopped another way
1.1%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of Vitapharma.be itself: 0.3% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,984 companies, not a prediction for Vitapharma.be. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €3,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.06 (1.02 in 2024), below the usual 1.5. Short-term debt is 88.2% and cash 53.2% of total assets. 88.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 15-12-2025, 136 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
136 days early
2024
141 days early
2023
155 days early
2022
143 days early
2021
31 days late
2019
61 days early
2018
120 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 104 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 10 December (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
30-09-2026 year end10-11-2026 today30-04-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0883997424
Change of role: CALLENS Stefan, from statutory manager to director
“Airco en luchtbehandelingstechnieken; Handelsvertegenwoordiging in de ruimste zin” (deed in Dutch) · Gazette deed
New manager
Stefan Callens appointed, Isabelle Van Eynde resigned · General meeting of 06-06-2019 · Gazette deed
First establishment
THUISAPOTHEEK, Jan Albert De Rooverstraat 13, Temse
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Vitapharma.be Temse | €379,287 | €51,143 | 11.8% | - |
| TOMMASI Herentals | €366,567 | €55,368 | 52.2% | - |
| HET IMKERSHUIS VAN ONGEVAL Ninove | €292,971 | €40,519 | 17.8% | - |
| APOTHEEK BEAUPREZ - AFSCHRIFT Lokeren | €446,619 | €33,932 | 92.6% | - |
| S.N.L. Ghent | €475,709 | €87,959 | 56.0% | - |
| BELARTISAN Boechout | €480,201 | €47,094 | 76.3% | - |
| GLOBAL TECHNICS CONSULTING Heusden-Zolder | €313,857 | €45,767 | 60.0% | - |
These companies have the same main activity as Vitapharma.be: other retail sale of food (NACE 47279). They are comparable in size and age: total assets between €293,000 and €480,000, founded between 2004 and 2010.
Official details
Source: KBO- Status
- Active since 05-10-2006Normal situation
- Activity
- Other retail sale of foodNACE 47279and 2 others
- Establishment unit
- 2.156.710.9659140 Temse, since 01-11-2006
- Financial year end
- 30 September
- Peppol
- Reachable since 19-12-2025
Annual accounts to 30-09-2025
- €379,287▼ 0.8%
- Filing
- Filed on 15-12-2025, 136 days before the end of the filing period
Insights on Vitapharma.be
Vitapharma.be files the micro format. That format states no turnover. The gross margin rose from €3,778 in 2007 to €51,143 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Vitapharma.be
- What is the company number of Vitapharma.be?
- The company number of Vitapharma.be is 0883.997.424. The VAT number is the same number with BE in front: BE 0883.997.424.
- Where is Vitapharma.be based?
- The registered office is at Jan Albert De Rooverstraat 13, 9140 Temse.Company details
- What does Vitapharma.be do?
- According to the KBO register, the main activity is other retail sale of food (NACE 47279).
- What is the legal form of Vitapharma.be?
- Vitapharma.be is a private limited company (BV).
- When was Vitapharma.be founded?
- Vitapharma.be was founded on 05-10-2006.
- Is Vitapharma.be still active?
- Yes, Vitapharma.be is an active enterprise in the KBO register.
- What is the turnover of Vitapharma.be?
- The turnover in financial year 2025 is ≈ €400,000. This figure is estimated from the gross margin of €51,143 and 45 comparable companies (NACE 472). It probably lies between €230,000 and €550,000.Financials
- Is Vitapharma.be profitable?
- In financial year 2025, Vitapharma.be made a profit of €4,598.
- Where can I find the annual accounts of Vitapharma.be?
- Vitapharma.be filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Vitapharma.be due?
- Vitapharma.be must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.